These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28830241)

  • 21. Addressing Metabolic Comorbidity in Individuals With Intellectual and Developmental Disability on Antipsychotics: A Clinical Case Series.
    Stogios N; Hahn MK; Lunsky Y; Desarkar P; Agarwal SM
    J Clin Psychopharmacol; 2023 Jan-Feb 01; 43(1):60-63. PubMed ID: 36394921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychiatric Presentations and Medication Use in Older Adults With Intellectual and Developmental Disabilities.
    Wise E; Holingue C; Klein A; Caoili A; Charlot L; Barnhill J; Beasley JB
    Am J Geriatr Psychiatry; 2022 Jan; 30(1):65-77. PubMed ID: 34210596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Demographic and diagnostic profiles of older people with intellectual disability and prescription of antipsychotics.
    Axmon A; Ahlström G; Gagnemo Persson R; Eberhard J
    Soc Psychiatry Psychiatr Epidemiol; 2019 Aug; 54(8):937-944. PubMed ID: 30903237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of the emotional development approach on psychotropic medication in adults with intellectual and developmental disabilities: a retrospective clinical analysis.
    Barrett BF; Wehmeyer M; Kolb J; Ostermann T; Sappok T
    J Intellect Disabil Res; 2024 Aug; 68(8):941-953. PubMed ID: 38545626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using administrative health data to identify individuals with intellectual and developmental disabilities: a comparison of algorithms.
    Lin E; Balogh R; Cobigo V; Ouellette-Kuntz H; Wilton AS; Lunsky Y
    J Intellect Disabil Res; 2013 May; 57(5):462-77. PubMed ID: 23116328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychotropic Use Among Youths With Intellectual and Developmental Disabilities.
    McLaren JL; Lichtenstein JD; Metcalfe JD; Charlot LR; Drake RE; Beasley JB
    Psychiatr Serv; 2021 Sep; 72(9):988-997. PubMed ID: 33882691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antipsychotic and antidepressant prescribing for 704 297 children and young people with and without intellectual disabilities: record linkage study.
    Henderson A; Kinnear D; Fleming M; Stanley B; Greenlaw N; Young-Southward G; Pell JP; Cooper SA
    Br J Psychiatry; 2021 Jan; 218(1):58-62. PubMed ID: 33541472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health profiles and associated service use among adults with HIV and intellectual and developmental disabilities.
    Lunsky Y; Durbin A; Brown HK; Bansal S; Heifetz M; Antoniou T
    AIDS; 2017 Mar; 31(5):697-705. PubMed ID: 27922856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder.
    Sultan RS; Wang S; Crystal S; Olfson M
    JAMA Netw Open; 2019 Jul; 2(7):e197850. PubMed ID: 31348506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in community and hospital-based health care use during the COVID-19 pandemic for adults with and without intellectual and developmental disabilities.
    Durbin A; Balogh R; Lin E; Palma L; Plumptre L; Lunsky Y
    J Intellect Disabil Res; 2022 May; 66(5):399-412. PubMed ID: 35353400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes over a decade in psychotropic prescribing for people with intellectual disabilities: prospective cohort study.
    Henderson A; Mcskimming P; Kinnear D; McCowan C; McIntosh A; Allan L; Cooper SA
    BMJ Open; 2020 Sep; 10(9):e036862. PubMed ID: 32912946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prescriptions for Antipsychotics: Youth with Intellectual/Developmental Disabilities Compared to Youth without Intellectual/Developmental Disabilities.
    Marquis S; Marquis NE; Lunsky Y; McGrail KM; Baumbusch J
    J Autism Dev Disord; 2024 Apr; ():. PubMed ID: 38678514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brief report: cervical cancer screening in women with intellectual and developmental disabilities who have had a pregnancy.
    Brown HK; Plourde N; Ouellette-Kuntz H; Vigod S; Cobigo V
    J Intellect Disabil Res; 2016 Jan; 60(1):22-7. PubMed ID: 26359630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effectiveness of aripiprazole in the management of problem behaviour in people with intellectual disabilities, developmental disabilities and/or autistic spectrum disorder--a systematic review.
    Deb S; Farmah BK; Arshad E; Deb T; Roy M; Unwin GL
    Res Dev Disabil; 2014 Mar; 35(3):711-25. PubMed ID: 24405794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Traumatic Brain Injury Incidence in Adults with Intellectual and Developmental Disabilities.
    Seto K; Lloyd M; Chan V; Chung H; Balogh R
    Can J Neurol Sci; 2021 May; 48(3):392-399. PubMed ID: 32814611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality of prescribing of antipsychotic medication for people with intellectual disability under the care of UK mental health services: a cross-sectional audit of clinical practice.
    Paton C; Bhatti S; Purandare K; Roy A; Barnes T
    BMJ Open; 2016 Dec; 6(12):e013116. PubMed ID: 27920085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Looking across health and healthcare outcomes for people with intellectual and developmental disabilities and psychiatric disorders: population-based longitudinal study.
    Lin E; Balogh R; Chung H; Dobranowski K; Durbin A; Volpe T; Lunsky Y
    Br J Psychiatry; 2021 Jan; 218(1):51-57. PubMed ID: 33161927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central nervous system medication use in older adults with intellectual disability: Results from the successful ageing in intellectual disability study.
    Chitty KM; Evans E; Torr JJ; Iacono T; Brodaty H; Sachdev P; Trollor JN
    Aust N Z J Psychiatry; 2016 Apr; 50(4):352-62. PubMed ID: 26019276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study.
    Sheehan R; Hassiotis A; Walters K; Osborn D; Strydom A; Horsfall L
    BMJ; 2015 Sep; 351():h4326. PubMed ID: 26330451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk Factors Associated With COVID-19 Outcomes Among People With Intellectual and Developmental Disabilities Receiving Residential Services.
    Landes SD; Turk MA; Damiani MR; Proctor P; Baier S
    JAMA Netw Open; 2021 Jun; 4(6):e2112862. PubMed ID: 34100935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.